Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,433 public trials 2,002 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Completed

Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer

NCT00068341

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • Wilshire Oncology Medical Group, Incorporated - Pomona Pomona, California, United States
View Trial Details
Completed

A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer

NCT01973309

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cedars-Sinai Medical Center/ Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas, Texas, United States
  • Texas Oncology-Tyler Tyler, Texas, United States
View Trial Details
Completed

Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

NCT01875666

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • IU Simon Cancer Center Indianapolis, Indiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years

NCT01810393

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Clinique Du Docteur Calabet; Cromg Agen, France
  • Clinique De L Europe; Radiotherapie Chimiotherapie Amiens, France
  • ICO Paul Papin; Oncologie Medicale. Angers, France
  • HOP Prive Arras Les Bonnettes; Chimiotherapie Arras, France
View all 61 locations
View Trial Details
Completed

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

NCT01139957

Conditions
Adnexal Diseases, Breast Carcinoma, Breast Diseases, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
View all 141 locations
View Trial Details

Related conditions